LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 108

Search options

  1. Article ; Online: Anti-cytokine autoantibodies: mechanistic insights and disease associations.

    Cheng, Aristine / Holland, Steven M

    Nature reviews. Immunology

    2023  Volume 24, Issue 3, Page(s) 161–177

    Abstract: Anti-cytokine autoantibodies (ACAAs) are increasingly recognized as modulating disease severity in infection, inflammation and autoimmunity. By reducing or augmenting cytokine signalling pathways or by altering the half-life of cytokines in the ... ...

    Abstract Anti-cytokine autoantibodies (ACAAs) are increasingly recognized as modulating disease severity in infection, inflammation and autoimmunity. By reducing or augmenting cytokine signalling pathways or by altering the half-life of cytokines in the circulation, ACAAs can be either pathogenic or disease ameliorating. The origins of ACAAs remain unclear. Here, we focus on the most common ACAAs in the context of disease groups with similar characteristics. We review the emerging genetic and environmental factors that are thought to drive their production. We also describe how the profiling of ACAAs should be considered for the early diagnosis, active monitoring, treatment or sub-phenotyping of diseases. Finally, we discuss how understanding the biology of naturally occurring ACAAs can guide therapeutic strategies.
    MeSH term(s) Humans ; Autoantibodies ; Autoimmunity ; Cytokines ; Inflammation
    Chemical Substances Autoantibodies ; Cytokines
    Language English
    Publishing date 2023-09-19
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2062776-2
    ISSN 1474-1741 ; 1474-1733
    ISSN (online) 1474-1741
    ISSN 1474-1733
    DOI 10.1038/s41577-023-00933-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Correlation of adverse effects and antibody responses following homologous and heterologous COVID-19 prime-boost vaccinations.

    Cheng, Aristine / Sheng, Wang-Huei / Chang, Shan-Chwen

    Journal of the Formosan Medical Association = Taiwan yi zhi

    2023  Volume 122, Issue 5, Page(s) 434–435

    MeSH term(s) Humans ; Antibody Formation ; COVID-19/prevention & control ; Vaccination/adverse effects ; Drug-Related Side Effects and Adverse Reactions ; Iatrogenic Disease ; Antibodies, Viral
    Chemical Substances Antibodies, Viral
    Language English
    Publishing date 2023-01-03
    Publishing country Singapore
    Document type Letter ; Comment
    ZDB-ID 2096659-3
    ISSN 1876-0821 ; 0929-6646
    ISSN (online) 1876-0821
    ISSN 0929-6646
    DOI 10.1016/j.jfma.2022.12.020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Anticytokine autoantibodies: Autoimmunity trespassing on antimicrobial immunity.

    Cheng, Aristine / Holland, Steven M

    The Journal of allergy and clinical immunology

    2021  Volume 149, Issue 1, Page(s) 24–28

    Abstract: Anticytokine autoantibodies can cause immunodeficiency or dysregulate immune responses. They may phenocopy genetically defined primary immunodeficiencies. We review current anti-type 1 and anti-type 2 interferon; anti-IL-12/23, anti-IL-17, and anti-GM- ... ...

    Abstract Anticytokine autoantibodies can cause immunodeficiency or dysregulate immune responses. They may phenocopy genetically defined primary immunodeficiencies. We review current anti-type 1 and anti-type 2 interferon; anti-IL-12/23, anti-IL-17, and anti-GM-CSF autoantibodies; HLA associations; disease associations; and mechanistically based treatment options. Suspecting the presence of these autoantibodies in patients and identifying them at the onset of symptoms should ameliorate disease and improve outcomes.
    MeSH term(s) Autoantibodies/immunology ; Autoimmunity ; Cytokines/immunology ; Humans
    Chemical Substances Autoantibodies ; Cytokines
    Language English
    Publishing date 2021-12-24
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Review
    ZDB-ID 121011-7
    ISSN 1097-6825 ; 1085-8725 ; 0091-6749
    ISSN (online) 1097-6825 ; 1085-8725
    ISSN 0091-6749
    DOI 10.1016/j.jaci.2021.11.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Concerns About the Association Between Poor Clinical Outcomes and the Minimum Inhibitory Concentrations Determined by Etest.

    Cheng, Aristine / Chuang, Yu-Chung

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2019  Volume 69, Issue 5, Page(s) 902–903

    MeSH term(s) Bacteremia ; Daptomycin ; Disk Diffusion Antimicrobial Tests ; Humans ; Microbial Sensitivity Tests ; Vancomycin
    Chemical Substances Vancomycin (6Q205EH1VU) ; Daptomycin (NWQ5N31VKK)
    Language English
    Publishing date 2019-02-04
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciz079
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Herpes zoster aseptic meningitis and Ramsay Hunt syndrome in an immunocompetent young adult post mild COVID-19 - A coincidence?

    Chu, Wen-Kai / Lin, Kuan-Yin / Sun, Hsin-Yun / Chen, Yee-Chun / Cheng, Aristine

    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

    2023  Volume 56, Issue 5, Page(s) 1114–1115

    MeSH term(s) Young Adult ; Humans ; Herpes Zoster Oticus/complications ; Herpes Zoster Oticus/diagnosis ; Herpes Zoster Oticus/drug therapy ; Meningitis, Aseptic/diagnosis ; COVID-19/complications ; COVID-19/diagnosis ; Herpes Zoster/complications ; Herpes Zoster/diagnosis ; Herpes Zoster/drug therapy ; Chickenpox
    Language English
    Publishing date 2023-04-26
    Publishing country England
    Document type Letter
    ZDB-ID 1497590-7
    ISSN 1995-9133 ; 1684-1182 ; 0253-2662
    ISSN (online) 1995-9133
    ISSN 1684-1182 ; 0253-2662
    DOI 10.1016/j.jmii.2023.04.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Nontuberculous mycobacterial infection mimicking gynecologic malignancy in a woman living with HIV.

    Tsai, Tsung-Yu / Tai, Yi-Jou / Cheng, Aristine / Lee, Tai-Fen / Huang, Szu-Ting / Lin, Kuan-Yin / Hung, Chien-Ching

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

    2023  Volume 137, Page(s) 25–27

    Abstract: The weakened immune system in people living with HIV (PLWH) can lead to infectious diseases occurring more aggressively and mimicking the clinical manifestations of malignancies. Mycobacterium sherrisii, a slow-growing nontuberculous mycobacterium, may ... ...

    Abstract The weakened immune system in people living with HIV (PLWH) can lead to infectious diseases occurring more aggressively and mimicking the clinical manifestations of malignancies. Mycobacterium sherrisii, a slow-growing nontuberculous mycobacterium, may cause opportunistic infections among PLWH. We present a case of a 41-year-old woman who initially presented with fever, vaginal spotting, and a bulky pelvic mass, raising suspicion of uterine malignancy. Following a surgical resection, she was pathologically diagnosed with leiomyoma and endometriosis. However, during an event of needlestick injury, she was unexpectedly found to be HIV-infected and the CD4 count was 157 cells/µL at diagnosis, which prompted a diagnostic work-up for opportunistic infections. The diagnosis of disseminated M. sherrisii infection was confirmed through cultures and special staining of specimens obtained from the pelvic tumor and blood. Subsequently, she was treated with a combination of ethambutol, azithromycin, and levofloxacin. Two months after treatment, abdominal and pelvic computed tomography revealed no evidence of recurrent tumor or abscess formation. Given the frequent association of pelvic masses with gynecologic malignancies in women living with HIV, it can be challenging to differentiate between a cancerous lesion and an infectious process, emphasizing the need for meticulous investigations to minimize the potential for misdiagnosis.
    MeSH term(s) Humans ; Female ; Adult ; Genital Neoplasms, Female/complications ; Genital Neoplasms, Female/diagnosis ; Neoplasm Recurrence, Local ; Mycobacterium Infections, Nontuberculous/diagnosis ; Mycobacterium Infections, Nontuberculous/drug therapy ; Mycobacterium Infections, Nontuberculous/microbiology ; HIV Infections/complications ; Opportunistic Infections
    Language English
    Publishing date 2023-10-11
    Publishing country Canada
    Document type Case Reports
    ZDB-ID 1331197-9
    ISSN 1878-3511 ; 1201-9712
    ISSN (online) 1878-3511
    ISSN 1201-9712
    DOI 10.1016/j.ijid.2023.10.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Disseminated Mycobacterium chimaera infection in a patient with adult-onset immunodeficiency syndrome: case report.

    Lin, Yi-Fu / Lee, Tai-Fen / Wu, Un-In / Huang, Chun-Fu / Cheng, Aristine / Lin, Kuan-Yin / Hung, Chien-Ching

    BMC infectious diseases

    2022  Volume 22, Issue 1, Page(s) 665

    Abstract: Background: Patients with adult-onset immunodeficiency syndrome due to anti-interferon-γ autoantibodies (AIGAs) are susceptible to disseminated Mycobacterium avium complex (MAC) infections. M. chimaera, a newly identified MAC species, is distinguished ... ...

    Abstract Background: Patients with adult-onset immunodeficiency syndrome due to anti-interferon-γ autoantibodies (AIGAs) are susceptible to disseminated Mycobacterium avium complex (MAC) infections. M. chimaera, a newly identified MAC species, is distinguished from the others due to the reduced virulence. Previous cases of disseminated M. chimaera infection have been linked to cardiothoracic surgery. Reports of disseminated M. chimaera in patients without a history of cardiothoracic surgery are rare.
    Case presentation: A 57-year-old Asian man, previously healthy, presented with fever, dry cough, exertional dyspnea, and decreased appetite. The delayed resolution of pneumonia despite antibiotic treatment prompted further imaging studies and biopsies from the lung and lymph node. The fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) demonstrated intense uptake in lung consolidations and diffuse lymphadenopathy. Cultures of the specimens obtained from sputum, blood, stool, lung tissue, and lymph node grew M. chimaera. Further immunological evaluation disclosed the presence of neutralizing AIGAs, which possibly led to acquired immunodeficiency and disseminated M. chimaera infection.
    Conclusions: We herein present the first case of adult-onset immunodeficiency due to AIGAs complicated with disseminated M. chimaera infection. Further immunological evaluation, including AIGAs, may be warranted in otherwise healthy patients who present with disseminated mycobacterial infection.
    MeSH term(s) Adult ; Chimera ; Humans ; Immunologic Deficiency Syndromes/complications ; Male ; Middle Aged ; Mycobacterium ; Mycobacterium Infections, Nontuberculous/microbiology ; Positron Emission Tomography Computed Tomography
    Language English
    Publishing date 2022-08-01
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 2041550-3
    ISSN 1471-2334 ; 1471-2334
    ISSN (online) 1471-2334
    ISSN 1471-2334
    DOI 10.1186/s12879-022-07656-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations.

    Cheng, Aristine / Hsieh, Ming-Ju / Chang, Sui-Yuan / Ieong, Si-Man / Cheng, Chien-Yu / Sheng, Wang-Huei / Chang, Shan-Chwen

    Journal of the Formosan Medical Association = Taiwan yi zhi

    2022  Volume 122, Issue 5, Page(s) 384–392

    Abstract: Background: Studies correlating reactogenicity and immunogenicity of COVID-19 vaccines are limited to BNT162b2, with inconsistent results. We investigated whether adverse reactions after other COVID-19 vaccines reliably predict humoral responses.: ... ...

    Abstract Background: Studies correlating reactogenicity and immunogenicity of COVID-19 vaccines are limited to BNT162b2, with inconsistent results. We investigated whether adverse reactions after other COVID-19 vaccines reliably predict humoral responses.
    Methods: Adult volunteers were recruited for homologous or heterologous prime-boost vaccinations with adenoviral (ChAdOx1, AstraZeneca) and/or mRNA (mRNA-1273, Moderna) vaccines administered either 4 or 8 weeks apart. Adverse effects were routinely solicited and recorded by subjects in a standard diary card for up to 84 days post booster vaccination. Anti-SARS-CoV-2 IgG titers were measured pre- (visit 1), and post-booster dose at days 14 (visit 2) and 28 (visit 3).
    Results: A total of 399 participants (75% women) with a median age of 41 (interquartile range, 33-48 IQR) years were included. Vaccine-induced antibody titers at days 14 and 28 were significantly higher among subjects who reported local erythema, swelling, pain, as well as systemic fever, chills, headache, myalgia, arthralgia, fatigue compared to those who did not experience local or systemic reactogenicity. Post-vaccination humoral responses did not correlate with the occurrence of skin rash and correlated weakly with gastrointestinal symptoms. A significant correlation between post-vaccination peak body temperature and anti-SARS-CoV-2 spike IgG at Day 14, independent of vaccine type and schedule, was found.
    Conclusion: Specific symptoms of reactogenicity such as post-vaccination injection site pain, swelling, erythema and fever, myalgia and fatigue are significantly predictive of the magnitude of the anti-SARS-CoV-2 antibody response.
    MeSH term(s) Adult ; Female ; Humans ; Middle Aged ; Male ; COVID-19 Vaccines/adverse effects ; Antibody Formation ; Myalgia/etiology ; BNT162 Vaccine ; COVID-19/prevention & control ; Drug-Related Side Effects and Adverse Reactions ; Vaccination/adverse effects ; Fatigue ; Fever/etiology ; Antibodies, Viral
    Chemical Substances COVID-19 Vaccines ; BNT162 Vaccine ; Antibodies, Viral
    Language English
    Publishing date 2022-12-15
    Publishing country Singapore
    Document type Journal Article
    ZDB-ID 2096659-3
    ISSN 1876-0821 ; 0929-6646
    ISSN (online) 1876-0821
    ISSN 0929-6646
    DOI 10.1016/j.jfma.2022.12.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Fatal myositis, rhabdomyolysis and compartment syndrome after ChAdOx1 nCoV-19 vaccination.

    Huang, Szu-Ting / Lee, Tai-Ju / Chen, Kai-Hsiang / Sun, Hsin-Yun / Chen, Wei-Ting / Hsieh, Song-Chou / Cheng, Aristine / Chen, Yee-Chun

    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

    2022  

    Language English
    Publishing date 2022-04-25
    Publishing country England
    Document type Letter
    ZDB-ID 1497590-7
    ISSN 1995-9133 ; 1684-1182 ; 0253-2662
    ISSN (online) 1995-9133
    ISSN 1684-1182 ; 0253-2662
    DOI 10.1016/j.jmii.2022.04.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A difficult-to-treat pleuropulmonary histoplasmosis in a patient with rheumatoid arthritis in Taiwan.

    Chu, Wen-Kai / Wu, Un-In / Lee, Tai-Fen / Cheng, Aristine / Chen, Kai-Hsiang / Lin, Kuan-Yin / Chen, Yee-Chun

    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

    2022  Volume 56, Issue 1, Page(s) 192–196

    Abstract: Amphotericin B and itraconazole are the primary agents for treating histoplasmosis. Newer azoles are alternatives for patients refractory to or intolerant of standard therapy. We report an 83-year-old woman with rheumatoid arthritis complicated with ... ...

    Abstract Amphotericin B and itraconazole are the primary agents for treating histoplasmosis. Newer azoles are alternatives for patients refractory to or intolerant of standard therapy. We report an 83-year-old woman with rheumatoid arthritis complicated with pleuropulmonary histoplasmosis who responded to liposomal amphotericin B, but progressed under voriconazole and posaconazole maintenance therapy.
    MeSH term(s) Female ; Humans ; Aged, 80 and over ; Histoplasmosis/complications ; Histoplasmosis/diagnosis ; Histoplasmosis/drug therapy ; Antifungal Agents/therapeutic use ; Taiwan ; Histoplasma ; Arthritis, Rheumatoid/complications ; Arthritis, Rheumatoid/drug therapy
    Chemical Substances Antifungal Agents
    Language English
    Publishing date 2022-12-13
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 1497590-7
    ISSN 1995-9133 ; 1684-1182 ; 0253-2662
    ISSN (online) 1995-9133
    ISSN 1684-1182 ; 0253-2662
    DOI 10.1016/j.jmii.2022.12.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top